BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18834899)

  • 1. Subchronic MK-801 behavioural deficits in rats: partial reversal by the novel nitrate GT 1061.
    Beninger RJ; Forsyth JK; Van Adel M; Reynolds JN; Boegman RJ; Jhamandas K
    Pharmacol Biochem Behav; 2009 Feb; 91(4):495-502. PubMed ID: 18834899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subchronic MK-801 treatment and post-weaning social isolation in rats: differential effects on locomotor activity and hippocampal long-term potentiation.
    Ashby DM; Habib D; Dringenberg HC; Reynolds JN; Beninger RJ
    Behav Brain Res; 2010 Sep; 212(1):64-70. PubMed ID: 20382186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats.
    Camarasa J; Marimón JM; Rodrigo T; Escubedo E; Pubill D
    Eur J Pharmacol; 2008 Jul; 589(1-3):132-9. PubMed ID: 18582864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding.
    Beninger RJ; Beuk J; Banasikowski TJ; van Adel M; Boivin GA; Reynolds JN
    Behav Pharmacol; 2010 Feb; 21(1):1-10. PubMed ID: 19949321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats.
    Li JT; Su YA; Guo CM; Feng Y; Yang Y; Huang RH; Si TM
    Eur J Pharmacol; 2011 Feb; 652(1-3):65-72. PubMed ID: 21114996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic prenatal MK-801 treatment on object recognition, cognitive flexibility, and drug-induced locomotor activity in juvenile and adult rat offspring.
    Gallant S; Welch L; Martone P; Shalev U
    Behav Brain Res; 2017 Jun; 328():62-69. PubMed ID: 28390877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanosine selectively inhibits locomotor stimulation induced by the NMDA antagonist dizocilpine.
    Tort AB; Mantese CE; dos Anjos GM; Dietrich MO; Dall'Igna OP; Souza DO; Lara DR
    Behav Brain Res; 2004 Oct; 154(2):417-22. PubMed ID: 15313029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.
    Csernansky JG; Martin M; Shah R; Bertchume A; Colvin J; Dong H
    Neuropsychopharmacology; 2005 Dec; 30(12):2135-43. PubMed ID: 15956997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
    David HN; Ansseau M; Lemaire M; Abraini JH
    Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia.
    Rung JP; Carlsson A; Rydén Markinhuhta K; Carlsson ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):827-32. PubMed ID: 15916843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats.
    Manahan-Vaughan D; von Haebler D; Winter C; Juckel G; Heinemann U
    Hippocampus; 2008; 18(2):125-34. PubMed ID: 17924525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two learning tasks provide evidence for disrupted behavioural flexibility in an animal model of schizophrenia-like behaviour induced by acute MK-801: a dose-response study.
    Lobellova V; Entlerova M; Svojanovska B; Hatalova H; Prokopova I; Petrasek T; Vales K; Kubik S; Fajnerova I; Stuchlik A
    Behav Brain Res; 2013 Jun; 246():55-62. PubMed ID: 23499708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs.
    Yee BK; Singer P; Chen JF; Feldon J; Boison D
    Eur J Neurosci; 2007 Dec; 26(11):3237-52. PubMed ID: 18005073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio).
    Swain HA; Sigstad C; Scalzo FM
    Neurotoxicol Teratol; 2004; 26(6):725-9. PubMed ID: 15451036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
    Enomoto T; Ishibashi T; Tokuda K; Ishiyama T; Toma S; Ito A
    Behav Brain Res; 2008 Jan; 186(2):197-207. PubMed ID: 17881065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-hit model: behavioural investigation of the effect of combined neonatal MK-801 administration and isolation rearing in the rat.
    Lim AL; Taylor DA; Malone DT
    J Psychopharmacol; 2012 Sep; 26(9):1252-64. PubMed ID: 22361477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative modulation of α₅ GABAA receptors in rats may partially prevent memory impairment induced by MK-801, but not amphetamine- or MK-801-elicited hyperlocomotion.
    Timić Stamenić T; Joksimović S; Biawat P; Stanković T; Marković B; Cook JM; Savić MM
    J Psychopharmacol; 2015 Sep; 29(9):1013-24. PubMed ID: 26105958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated treatment with the NMDA antagonist MK-801 disrupts reconsolidation of memory for amphetamine-conditioned place preference.
    Sadler R; Herzig V; Schmidt WJ
    Behav Pharmacol; 2007 Nov; 18(7):699-703. PubMed ID: 17912055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
    Karasawa J; Hashimoto K; Chaki S
    Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous alternation behaviour in rats: kynurenic acid attenuated deficits induced by MK-801.
    Hlinák Z; Krejcí I
    Behav Brain Res; 2006 Mar; 168(1):144-9. PubMed ID: 16343655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.